Xencor Inc

XNCR chart

Xencor Inc news

• An iShares ETF has an interest above 5% as BlackRock updates its Xencor (XNCR) ownership.

  Stock Titan · Oct 27, 5:28 PM EDT

• Can Xencor (NASDAQ:XNCR) Sustain Its Rally After Strong Trial Results?

  Kalkine Media · Oct 27, 12:40 PM EDT

• RBC Sees Xencor’s Kidney Cancer Data Moving The Needle

  Finimize · Oct 27, 12:02 PM EDT

• Xencor Sees Upside Potential After 'Exciting' Kidney Cancer Trial Data, RBC Capital Markets Says

  Yahoo Finance · Oct 27, 11:51 AM EDT

• XENCOR Maintained by Wells Fargo -- Price Target Raised to $44.00

  GuruFocus · Oct 27, 11:24 AM EDT

• Truist raises Xencor stock price target on kidney cancer drug data

  Investing.com · Oct 27, 11:03 AM EDT

• RBC Capital maintains Outperform rating on Xencor, $43 price target

  TradingView · Oct 27, 10:11 AM EDT

• Xencor, Inc. (XNCR) PT Raised to $40 at Truist Securities

  StreetInsider · Oct 27, 9:36 AM EDT

• Xencor (NASDAQ:XNCR) Stock Price Target Raised at Wedbush

  MarketBeat · Oct 27, 9:26 AM EDT

• Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma - Slideshow

  Seeking Alpha · Oct 27, 9:05 AM EDT

• RBC Raises Price Target on Xencor to $43 From $20, Keeps Outperform, Speculative Risk

  marketscreener.com · Oct 27, 7:44 AM EDT

• Wells Fargo raises Xencor stock price target on kidney cancer data

  Investing.com · Oct 27, 6:39 AM EDT

Xencor Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-KCURRENT REPORT2026-10-26
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-07-29
• 8-K8-K2026-06-18
• 10-Q10-Q2026-05-06
• 8-K8-K2026-05-06
• 8-K8-K2026-05-05
• DEF 14ADEF 14A2026-04-27
• 8-K8-K2026-04-27
• 8-K8-K2026-03-09
• 8-K8-K2026-03-04

About Xencor Inc

Ticker

XNCR (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Pasadena, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1326732

Frequently asked questions